Carbohydrates in transplantation

Current Opinion in Chemical Biology

Volumn 3, Issue 6, 1999, Pages 650-658

  Chen, Xi ^a   Andreana, Peter R ^a   Wang, Peng George ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CARBOHYDRATE; EPITOPE; OLIGOSACCHARIDE;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; BLOOD GROUP ABO INCOMPATIBILITY; CARBOHYDRATE SYNTHESIS; CYTOTOXICITY; DRUG SYNTHESIS; EPITHELIUM CELL; GENETIC ENGINEERING; GRAFT REJECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY EPITHELIUM; NONHUMAN; REVIEW; XENOTRANSPLANTATION;

ANIMALIA; PRIMATES; SUS SCROFA;

EID: 0032707333     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(99)00022-8     Document Type: Review

References (52)

1. Lafferty K.J. A few steps along the path to adult transplantation tolerance. Transplant Proc. 31:1999;11S-13S.
2. Calne R. Future concepts in transplantation. Transplant Proc. 31:1999;21-24.
3. Lavitrano M., Stoppacciaro A., Bacci M.L., Forni M., Fioretti D., Pucci L., Di Stefano C., Lazzereschi D., Rughetti A., Ceratta S.et al. Human decay accelerating factor transgenic pigs for xenotransplantation obtained by sperm-mediated gene transfer. Transplant Proc. 31:1999;972-974.
4. Ierino F.L., Gojo S., Banerjee P.T., Giovino M., Xu Y.-X., Gere J., Kaynor C., Awwad M., Monroy R., Rembert J.et al. Transfer of swine major histocompatibility complex class II genes into autologous bone marrow cells of baboons for the induction of tolerance across xenogeneic barriers. Transplantation. 67:1999;1119-1128.
5. Martin U., Steinhoff G., Kiessig V., Chikobava M., Anssar M., Morschheuser T., Lapin B., Haverich A. Porcine endogenous retrovirus is transmitted neither in vivo nor in vitro from porcine endothelial cells to baboons. Transplant Proc. 31:1999;913-914.
6. Tucker A.W., Galbraith D., McEwan P., Onions D. Evaluation of porcine cytomegalovirus as potential zoonotic agent in xenotransplantation. Transplant Proc. 31:1999;915.
7. Bach F.H., Turman M.A., Vercellotti G.M., Platt J.L., Dalmasso A.P. Accommodation: a working paradigm for progressing toward clinical disordant xenografting. Transplant Proc. 23:1991;205-207.
8. Cooper D.K.C., Human P.A., Lexer G., Rose A.G., Reese J., Keraan M., Du Toit E. Effect of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon. J Heart Transplant. 7:1988;238-246.
9. Galili U., Shohet S.B., Kobrin E., Stultz C.L.M., Macher B.A. Man, apes and Old World monkeys differ form other mammals in the expression of α-galactosyl epitopes on nucleated cells. J Biol Chem. 263:1988;17755-17762.
10. Cooper D.K.C., Koren E., Oriol R. Oligosaccharides and discordant xenotransplantation. Immunol Rev. 141:1994;31-58.
11. Samuelsson B.E., Rydberg L., Breimer M.E., Backer A., Gustavsson M., Holgersson J., Karlsson E., Uyterwaal A.C., Cairns T., Welsh K. Natural antibodies and human xenotransplantation. Immunol Rev. 141:1994;151-168.
12. Simon P.M. Pharmaceutical oligosaccharides. Drug Discov Today. 1:1996;522-528.
13. Galili U. Significance of anti-Gal IgG in chronic xenograft rejection. Transplant Proc. 31:1999;940-941.
14. Koike K., Sugimoto M., Sato S., Ito Y., Nakahara Y., Ogawa T. Total synthesis of globotriaosyl-E and Z-ceramides and isoglobotriaosyl-E-ceramide. Carbohydr Res. 163:1987;189-208.
15. Reddy G.V., Jain R.K., Bhatti B.S., Matta K.L. Synthesis of alpha-D-galactopyranosyl-linked oligosaccharides containing the alpha-Gal→beta-Gal→GlcNAc sequence employing methyl-2,3,4,6-tetra-O-(4-methoxybenzyl)-1-thio-beta-D-galactopyranoside as an efficient glycosyl donor. Carbohydr Res. 263:1994;67-77.
16. Zhang W., Wang J.Q., Li J., Yu L.B., Wang P.G. A large-scale synthesis of an α-galactosyl trisaccharide epitope involved in the hyperacute rejection upon xenotransplantation. J Carbohydr Chem. 1999;. in press.
17. Joziasse D.H., Shaper J.H., Shaper N.L. The α1,2-galactosyl-transferase gene. Galili U., Avila J.L. α-Gal and anti-Gal. 1999;25-48 Kluwer Academic/Plenum Publishers.
18. Fang J.W., Li J., Chen X., Zhang Y.N., Wang J.Q., Guo Z.M., Zhang W., Yu L.B., Brew K., Wang P.G. Highly efficient chemoenzymatic synthesis of α-galactosyl epitopes with a recombinant α(1,3)-galactosyltransferase. J Am Chem Soc. 120:1998;6635-6638.
19. Fang J.W., Chen X., Zhang W., Wang J.Q., Andreana P., Wang P.G.A. unique chemoenzymatic synthesis of α-Gal epitope derivatives containing free amino groups: efficient separation and further manipulation. J Org Chem. 64:1999;4089-4094.
20. Loizumi S., Endo T., Tabata K., Ozaki A. Large-scale production of UDP-galactose and globotriose by coupling metabolically engineered bacteria. Nat Biotechnol. 16:1998;847-850.
21. Endo T., Koizumi S., Tabata K., Kakita S., Ozaki A. Large-scale production of N-acetyllactosamine through bacterial coupling. Carbohydr Res. 316:1999;179-183.
22. Wang T.G. New technologies for bioartificial organs. Artif Organs. 22:1998;68-74.
23. Bannett A.D., McAlack R.F., Raja R., Baquero A., Morries M. Experience with known ABO-mismatched renal transplants. Transplant Proc. 19:1987;4543-4546.
24. Bannett A.D., McAlack R.F., Morris M., Chopek M.W., Platt J.L. ABO incompatible renal transplantation: a qualitative analysis of native endothelial tissue ABO antigens after transplantation. Transplant Proc. 21:1989;783-785.
25. Cooper D.K., Ye Y., Niekrasz M., Kehoe M., Martin M., Neethling F.A., Kosanke S., DeBault L.E., Worsley G., Zuhdi N.et al. Specific intravenous carbohydrate therapy, a new concept in inhibiting antibody-mediated rejection-experience with ABO-incompatible cardiac allografting in the baboon. Transplantation. 56:1993;769-777.
26. Bach F.H., Turman M.A., Vercellotti G.M., Platt J.L., Dalmasso A.P. Accommodation: a working paradigm for progressing toward clinical discordant xenografting. Transplant Proc. 23:1991;205-207.
27. Cooper D.K.C. Xenoantigens and xenoantibodies. Xenotransplantation. 5:1998;6-17.
28. Bühler L., Friedman T., Iacomini J., Cooper D.K.C. Xenotransplantation - state-of-the-art update. Front Biosci. 4:1999;D416-D432.
29. Lambrigts D., Sachs D.H., Cooper D.K.C. Discordant organ xenotransplantation in primates. Transplantation. 66:1998;547-561.
30. Xu Y., Lorf T., Sablinski T., Gianello P., Bailin M., Monroy R., Kozlowski T., Cooper D.K.C., Sachs D.H. Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galα1-3Galβ1-4βGlc-X immunoaffinity column. Transplantation. 65:1998;172-179. Reports the recent application of α-Gal trisaccharide (1 and 2; Figure 1) immunoaffinity columns in a pig-to-baboon kidney xenotransplantation model. α-Gal trisaccharide 2 was demonstrated to be more effective than its type 2 derivatives. In vivo experiments in preventing HAR by removing anti-Gal from baboon plasma using an α-Gal 2 column was compared to hemoperfusion through a pig liver. Column perfusion was shown to cause less hypotension and a reduction in platelets.
31. Ye Y., Neethling F.A., Niekrasz M., Richards S.V., Koren E., Merhav H., Kosanke S., Oriol R., Cooper D.K.C. Evidence that intravenously administered α galactosyl carbohydrates reduce baboon serum cytotoxicity to pig kidney cells (PK15) and transplanted pig hearts. Transplantation. 58:1994;330-337.
32. Taniguchi S., Neethiling F.A., Korchagina E.Y., Bovine N., Ye Y., Kobayashi T., Miekrasz M., Li S., Koren E., Oriol R., Cooper D.K.C. In vivo immunoadsorption of anti-pig antibodies in baboons using a specific Galα1-3Gal column. Transplantation. 62:1996;1379-1384.
33. Kozlowski T., Ierino F.L., Lambrights D., Foley A., Andrews D., Awwad M., Monroy R., Cosimi A.B., Cooper D.K.C., Sachs D.H. Depletion of anti-Galα1-3Gal antibody in baboons by specific immunoaffinity columns. Xenotransplantation. 5:1998;122-131. Detailed studies were made of the depletion of anti-Gal in baboons by α-Gal columns under different conditions, such as immunologically naïve, immunosuppressive therapy treatment or conditioning regimen treatment with multiple or single procedures for whole blood or plasma only. Immunosuppressive reagent therapy and splenectomy can delay the return of anti-Gal, whereas perfusion of blood or plasma has the similar effect of removing anti-Gal although the latter technique is more suitable for multiple adsorption.
34. Kozlowski T., Shimizu A., Lambrigts D., Yamada K., Fuchimoto Y., Glaser R., Monroy R., Xu Y., Awwad M., Colvin R.B.et al. Porcine kidney and heart transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption. Transplantation. 67:1999;18-30.
35. Klein E., Euler M., Vercellotti J. Capture of anti-(Galα1-3Gal) antibodies by immobilized Galα1-3Gal oligomers derived form carrageenan. Biotechnol Appl Biochem. 28:1998;189-199. An α-Gal solid phase was prepared by immobilizing α-Gal disaccharide derived from λ-carrageenan (a natural source polysaccharide) to a hydrazide-modified microporous nylon membrane.
36. Simon P., Neethling F.A., Taniguchi S., Good P.L., Zopf D., Hancock W.W., Cooper D.K.C. Intravenous infusion of α-Gal oligosaccharides in baboons delays hyperacute rejection of porcine heart xenografts. Transplantation. 65:1998;346-353. This is the first in vivo study using a synthetic pentasaccharide as an antagonist in preventing HAR by a pig-to-baboon heart xenotransplantation model. α-Gal trisaccharide 1 and pentasaccharide 3 were the most effective inhibitors as determined by an in vitro complement-mediated cytotoxicity assay. Detailed measurements of pharmacokinetic parameters were made in baboons and the data obtained indicated that the serum half-life for oligosaccharides was 50 min. In vivo experiments implied that intravenous α-Gal oligosaccharides alone can only delay but do not abolish HAR.
37. Neethling F.A., Koren E., Ye Y., Richards S.V., Kujundzic M., Oriol R., Cooper D.K.C. Protection of pig kidney (PK15) cells from the cytotoxic effect of anti-pig antibodies by α-galactosyl oligosaccharides. Transplantation. 57:1994;959-963.
38. Nagasaka T., Kobayashi T., Muramatsu H., Fujimoto H., Matsuo I., Ajisaka K., Kadomatsu K., Hayashi S., Yokoyama I., Hayakawa A.et al. α-Galactosyl oligosaccharides conjugated with polyethylene glycol as potential inhibitors of hyperacute rejection upon xenotransplantation. Biochem Biophys Res Commun. 232:1997;731-736.
39. Hamadeh R.M., Galili U., Zhou P., Griffiss J.M. Anti-alpha-galactosyl immunoglobulin A (IgA), IgG, and IgM in human secretions. Clin Diagn Lab Immunol. 2:1995;125-131.
40. Galili U., Anaraki F., Thall A., Hill-Black C., Radic M. One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody. Blood. 82:1993;2485-2493.
41. McMorrow I.M., Comrack C.A., Sachs D.H., DerSimonian H. Heterogeneity of human anti-pig natural antibodies cross-reactive with the Gal(alpha1,3)Galactose epitope. Transplantation. 64:1997;501-510.
42. Buchs J.P., Nydegger U.E. Development of an ABO-ELISA for the quantitation of human blood group anti-A and anti-B IgM and IgG antibodies. J Immunol Methods. 118:1989;37-46.
43. 4-old compared with the α-Gal monomer in inhibition ELISA for IgA and IgM in human serum using mouse laminin as the antigen source.
44. Morozumi K., Kobayashi T., Usami T., Oikawa T., Ohtsuka Y., Kato M., Takeuchi O., Koyama K., Matsuda H., Yokoyama I., Takagi H. Significance of histochemical expression of Hanganutziu-Deicher antigens in pig, baboon and human tissues. Transplant Proc. 31:1999;942-944.
45. Lim F., Sun A.M. Microencapsulated islets as bioartificial endocrine pancreas. Science. 210:1980;908-910.
46. Tashiro H., Iwata H., Warnock G.L., Ikada Y., Tsuji T. Application of agarose microcapsules to allo-islet transplantation in a canine model. Transplant Proc. 30:1998;498-499.
47. Soon-Shiong P., Feldman E., Nelson R., Heintz R., Yao Q., Yao Z.W., Zheng T.L., Merideth N., Skjak-Braek Gespevik T.et al. Long-term reversal of diabetes by the injection of immunoprotected islets. Proc Natl Acad Sci USA. 90:1993;5843-5847.
48. Steenfos H.H., Agren M.S. A fibre-free alginate dressing in the treatment of split thickness skin graft donor sites. J Eur Acad Dermatol Venereol. 11:1998;252-256.
49. Jain K., Yang H., Cai B.-R., Haque B., Hurvitz A.I., Diehl C., Miyata T., Smith B.H., Stenzel K., Suthanthiran M., Rubin A. Retrievable, replaceable, macroencapsulated pancreatic islet xenografts: long-term engraftment without immunosuppression. Transplantation. 59:1995;319-324.
50. Orgill D.P., Butler C., Regan J.F., Barlow M.S., Yannas I.V., Compton C.C. Vascularized collagen-glycosaminoglycan matrix provides a dermal substrate and improves take of cultured epithelial autografts. Plast Reconstr Surg. 102:1998;423-429.
51. Elcin Y.M., Dixit V., Gitnick G. Hepatocyte attachment on modified chitosan membranes: in vitro evaluation for the development of liver organoids. Artif Organs. 22:1998;839-846.
52. Elcin Y.M., Dixit V., Lewin K., Gitnick G. Xenotransplantation of fetal porcine hepatocytes in rats using a tissue engineering approach. Artif Organs. 23:1999;146-152.